Bu sayfada
ASTH Astrana Health Inc. - Common Stock
NASDAQ · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 10, 2026
$35,88
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$18,4352 haftanın en düşüğü
$51,6052 haftanın en yükseği
Piyasa Değeri
$1.75B
P/E (TTM)
43.8
Hisse Başına Kâr (TTM)
$0.82
Gelir (TTM)
$3.84B
rozetleriniz
52 Haftlık Aralık
$18–$52
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$52
P/E
43.8
ROE
5.1%
Net Kâr Marjı
1.1%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
ASTH Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$35.88
Piyasa Değeri
$1.75B
P/E (TTM)
43.8
Hisse Başına Kâr (TTM)
$0.82
Gelir (TTM)
$3.84B
Temettü Verimi
0.45%
ROE (TTM)
5.1%
D/E Borç/Özsermaye (MRQ)
1.1
52 Haftlık Aralık
$18–$52
ASTH Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 27 Nisan 2015 | 1-for-10 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$3.18B2021-12-31 → 2025-12-31
Hisse Başına Kâr$0.462021-12-31 → 2025-12-31
Serbest Nakit Akışı$104M2021-12-31 → 2025-12-31
Net kar marjı1.1%2021-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | ASTH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 43.85Y ort. ≈37.1 | ≈37.1 | 22.4 | Aşırı değerli | |
| P/S (F/S) | 0.6 | · | 1.1 | Düşük değerli | |
| P/B (F/D) | 2.3 | · | 2.4 | Düşük değerli | |
| EV / EBITDA | 19.0 | · | 13.9 | Aşırı değerli | |
| Price / FCF (Fiyat / Serbest Nakit Akışı) | 16.8 | · | · | · | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | 15.3 | · | 14.2 | Düşük değerli | |
| EV / Revenue (EV / Gelir) | 0.7 | · | · | · | |
| EV / FCF | 22.6 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | ASTH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | 2.6%5Y ort. ≈5.5% | ≈5.5% | 3.8% | Aynı seviyede | |
| FAVÖK Marjı (TTM) | 4.3%5Y ort. ≈6.9% | ≈6.9% | 3.8% | Aynı seviyede | |
| Vergi Öncesi Kar Marjı (TTM) | 1.6%5Y ort. ≈4.8% | ≈4.8% | 3.0% | Zayıf | |
| Net Kâr Marjı (TTM) | 1.1%5Y ort. ≈2.8% | ≈2.8% | 2.4% | Ortalamanın altında | |
| ROA (TTM) | 2.2%5Y ort. ≈3.8% | ≈3.8% | 0.70% | En üst düzey | |
| ROE (TTM) | 5.1%5Y ort. ≈6.7% | ≈6.7% | 2.4% | En üst düzey | |
| ROIC | 2.6%5Y ort. ≈4.5% | ≈4.5% | 3.8% | Ortalamanın altında |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | ASTH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 1.15Y ort. ≈0.8 | ≈0.8 | 0.2 | Yüksek borç | |
| Cari Oran (MRQ) | 1.25Y ort. ≈1.8 | ≈1.8 | 1.2 | Aynı seviyede | |
| Quick Ratio (Cari Oran) | 1.35Y ort. ≈1.2 | ≈1.2 | 1.0 | Güçlü likidite | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 1.15Y ort. ≈0.8 | ≈0.8 | 0.3 | Yüksek borç |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | ASTH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 56.4%5Y ort. ≈43.0% | ≈43.0% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 40.6%5Y ort. ≈35.0% | ≈35.0% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 35.9% | · | · | · | |
| EPS YoY (EPS YB) | -48.9%5Y ort. ≈-20.9% | ≈-20.9% | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | -47.9%5Y ort. ≈-19.2% | ≈-19.2% | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | -22.6%5Y ort. ≈-10.0% | ≈-10.0% | · | · | |
| EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y) | -14.5% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | -20.8%5Y ort. ≈-6.0% | ≈-6.0% | · | · | |
| Net Income CAGR 5Y (Net Gelir Bileşik Yıllık Büyüme Oranı 5Y) | -9.8% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | ASTH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 1.85Y ort. ≈1.7 | ≈1.7 | 1.2 | En üst düzey | |
| Receivables Turnover (Alacak Devir Hızı) | 9.8 | · | 9.3 | Aynı seviyede | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$1.1M | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Temettü Verimi0.45%
Temettü Ödeme Oranı35.1%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-28.0%
Sonraki Rapor
Kas 04, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 12, 2026 | $0.40 | $0.34 | 16.7% |
| 31 Mart 2026 | May 13, 2026 | $0.29 | $0.30 | -4.9% |
| 31 Aralık 2025 | $0.12 | $0.11 | 11.0% | |
| 30 Eylül 2025 | $0.01 | $0.45 | -97.8% | |
| 30 Haziran 2025 | $0.19 | $0.37 | -48.7% | |
| 31 Mart 2025 | $0.14 | $0.25 | -44.4% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.18B | $2.03B | $1.39B | $1.14B | $774M | $687M | $561M | $520M | $356M | $306M | |
| Cost of Revenue | · | · | · | · | $596M | $539M | $468M | $361M | $273M | $255M | |
| SG&A Expense | $217M | $154M | $113M | $78M | $62M | $49M | $41M | $43M | $26M | $21M | |
| Operating Expenses | $3.10B | $1.95B | $1.30B | $1.04B | $676M | $607M | $528M | $431M | $321M | $294M | |
| Operating Income | $79M | $89M | $85M | $104M | $98M | $81M | $32M | $88M | $35M | $12M | |
| Interest Expense | · | · | $16M | $8M | $5M | $9M | $5M | $561.0K | $79.7K | $61.6K | |
| Interest Income | $12M | $15M | $14M | $2M | $2M | $3M | $2M | $1M | $1M | $504.7K | |
| Other Non-op | $-3M | $5M | $6M | $4M | $-4M | $1M | $3M | $2M | $168.1K | $233.7K | |
| Pretax Income | $40M | $81M | $90M | $87M | $78M | $178M | $26M | $83M | $50M | $19M | |
| Income Tax | $16M | $31M | $32M | $41M | $32M | $56M | $8M | $22M | $4M | $9M | |
| Net Income | $22M | $43M | $61M | $45M | $69M | $38M | $14M | $11M | $26M | $11M | |
| EPS (Basic) | $0.46 | $0.91 | $1.30 | $1.00 | $1.57 | $1.03 | $0.41 | $0.33 | $1.01 | $0.46 | |
| EPS (Diluted) | $0.46 | $0.90 | $1.29 | $0.99 | $1.52 | $1.01 | $0.39 | $0.29 | $0.90 | $0.41 | |
| Shares (Basic) | 49,075,727 | 47,597,295 | 46,553,256 | 44,971,143 | 43,828,664 | 36,527,672 | 34,708,429 | 32,893,940 | 25,525,786 | 24,673,081 | |
| Shares (Diluted) | 49,369,685 | 47,974,334 | 46,943,140 | 45,602,415 | 45,403,085 | 37,448,430 | 36,403,279 | 37,914,886 | 28,661,735 | 27,970,431 | |
| EBITDA | $124M | $117M | $102M | $122M | $116M | $99M | $51M | $108M | $54M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $429M | $288M | $294M | $288M | $233M | $193M | $103M | $107M | $100M | $55M | |
| Short-term Investments | · | $2M | $2M | $6M | $53M | $68M | $117M | $1M | $1M | $1M | |
| Receivables | $374M | $276M | · | $50M | $11M | $7M | $11M | $8M | $8M | $22M | |
| Prepaid Expense | $26M | $25M | $17M | $15M | $19M | $17M | $10M | $7M | $5M | $2M | |
| Current Assets | $863M | $638M | $462M | $428M | $404M | $339M | $329M | $173M | $144M | $81M | |
| PP&E (Net) | $57M | $14M | · | · | · | · | · | $13M | $14M | $10M | |
| PP&E (Gross) | $87M | $39M | · | · | · | · | · | $27M | $26M | $19M | |
| Accum. Depreciation | $30M | $25M | · | · | · | · | · | $14M | $12M | $8M | |
| Goodwill | $865M | $419M | $279M | $269M | $246M | $232M | $239M | $186M | $190M | $103M | |
| Intangibles | $271M | $118M | $72M | $77M | $83M | $87M | $103M | $87M | $104M | $108M | |
| Other Non-current Assets | $25M | $17M | $2M | $5M | $6M | $19M | $2M | $1M | $2M | $2M | |
| Total Assets | $2.22B | $1.35B | $933M | $966M | $867M | $817M | $729M | $513M | $491M | $350M | |
| Accounts Payable | $196M | $106M | $60M | $50M | $44M | $36M | $27M | $4M | $4M | $1M | |
| Current Liabilities | $615M | $366M | $219M | $149M | $115M | $115M | $105M | $72M | $110M | $51M | |
| Capital Leases | $32M | $31M | $36M | $20M | $13M | $16M | $11M | $517.3K | $619.0K | $0 | |
| Deferred Tax | $5M | $5M | $4M | $14M | $30M | $11M | $18M | $20M | · | · | |
| Other Non-current Liabilities | $17M | $15M | $4M | $20M | $15M | $0 | · | · | · | · | |
| Total Liabilities | $1.66B | $841M | $523M | $408M | $357M | $372M | $368M | $106M | $154M | $100M | |
| Long-term Debt | $1.04B | $435M | $278M | $204M | $184M | $241M | $232M | $0 | · | · | |
| Total Debt | $1.04B | $435M | $278M | · | $184M | $241M | $242M | · | · | · | |
| Common Stock | $49.0K | $48.0K | $47.0K | $47.0K | $45.0K | $42.0K | $36.0K | $34.6K | $32.3K | $25.1K | |
| Paid-in Capital | $471M | $426M | $371M | $360M | $311M | $261M | $160M | $163M | $158M | $88M | |
| Retained Earnings | $308M | $286M | $243M | $182M | $137M | $70M | $32M | $18M | $2M | $-773.3K | |
| Stockholders' Equity | $779M | $713M | $614M | $543M | $448M | $331M | $192M | $181M | $160M | $87M | |
| Liabilities + Equity | $2.22B | $1.35B | $933M | $966M | $867M | $817M | $729M | $513M | $491M | $350M | |
| Shares Outstanding | 48,885,358 | 47,929,872 | · | 46,575,699 | 44,630,873 | 42,249,137 | 35,908,057 | 34,578,040 | 32,304,876 | 25,067,953 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $46M | $28M | $18M | $18M | $18M | $18M | $18M | $19M | $19M | $18M | |
| Stock-based Comp | $39M | $35M | $22M | $16M | $7M | $3M | $2M | $1M | $3M | · | |
| Deferred Tax | $-4M | $-4M | $-12M | $-14M | $8M | $396.0K | $-7M | $-8M | $-21M | $-3M | |
| Amort. of Intangibles | $41M | $26M | $13M | $14M | $15M | $16M | $16M | $17M | $18M | · | |
| Other Non-cash | $12M | $-49M | $-20M | $18M | $-22M | $-7M | $-14M | $4M | $28M | · | |
| Operating Cash Flow | $115M | $52M | $68M | $82M | $70M | $46M | $14M | $25M | $52M | $22M | |
| CapEx | $10M | $8M | $29M | $23M | $19M | $1M | $1M | $1M | $2M | $3M | |
| Investing Cash Flow | $-539M | $-192M | $-66M | $-7M | $17M | $95M | $-181M | $-25M | $27M | $-9M | |
| Debt Issued | · | · | · | · | · | · | $250M | $8M | $5M | · | |
| Net Debt Issued | · | · | · | · | · | $0 | $248M | · | · | · | |
| Stock Issued | · | · | $0 | $0 | $40M | $0 | $0 | $200.0K | $2M | $11M | |
| Stock Repurchased | $26M | $900.0K | $10M | $9M | $6M | $537.0K | $8M | $5M | $3M | $517.5K | |
| Net Stock Activity | $-26M | $-900.0K | $-10M | $-9M | $34M | $-537.0K | $-7M | $-5M | $-1M | · | |
| Dividends Paid | $8M | $4M | $62M | $14M | $31M | $51M | $62M | $18M | $10M | $27M | |
| Financing Cash Flow | $569M | $135M | $3M | $-20M | $-48M | $-52M | $163M | $-11M | $-15M | $-17M | |
| Net Change in Cash | $145M | $-5M | $6M | $55M | $39M | $90M | $-4M | $-11M | $64M | $-4M | |
| Free Cash Flow | $104M | $44M | $40M | $59M | $51M | $45M | $13M | $24M | $50M | · | |
| Levered FCF | · | · | $29M | $55M | $48M | $38M | $9M | $24M | $50M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.5% | 4.4% | 6.1% | 9.1% | 12.7% | 11.7% | 5.8% | 17.0% | 9.8% | · | |
| Net Margin | 0.71% | 2.1% | 4.4% | 4.0% | 9.5% | 5.5% | 2.5% | 2.1% | 7.2% | · | |
| Pretax Margin | 1.2% | 4.0% | 6.5% | 7.6% | 10.1% | 26.0% | 4.6% | 15.9% | 13.9% | · | |
| EBITDA Margin | 3.9% | 5.8% | 7.4% | 10.7% | 14.9% | 14.4% | 9.1% | 20.7% | 15.2% | · | |
| ROA | 1.3% | 3.8% | 6.4% | · | 8.6% | 4.9% | 2.3% | 2.2% | 10.1% | · | |
| ROE | 3.0% | 6.5% | 10.5% | · | 16.6% | 14.5% | 7.6% | 6.4% | 32.3% | · | |
| ROIC | 2.6% | 4.8% | 6.1% | · | 9.8% | 9.7% | 5.1% | 35.7% | 20.3% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.7 | 2.1 | · | 3.5 | 2.9 | 3.1 | 2.4 | 1.3 | · | |
| Quick Ratio | 1.3 | 0.8 | 1.4 | · | 2.6 | 2.3 | 2.2 | 1.6 | 1.1 | · | |
| Debt / Equity | 1.3 | 0.6 | 0.5 | · | 0.4 | 0.7 | 1.3 | · | · | · | |
| LT Debt / Equity | 1.3 | 0.6 | 0.4 | · | 0.4 | 0.7 | 1.2 | · | · | · | |
| Interest Coverage | · | · | 5.3 | 13.2 | 18.2 | 8.5 | 6.8 | 157.8 | 441.0 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.8 | 1.8 | 1.5 | · | 0.9 | 0.9 | 0.9 | 1.0 | 1.4 | · | |
| Receivables Turnover | 9.8 | · | · | · | 87.6 | 76.1 | 59.8 | 67.8 | 27.9 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $15.94 | · | · | · | · | · | $5.33 | $5.22 | $4.95 | · | |
| Revenue / Share | $64.45 | $42.41 | $29.54 | $25.09 | $17.05 | $18.35 | $15.40 | $13.71 | $12.48 | · | |
| Cash Flow / Share | $2.32 | $1.09 | $1.45 | $1.80 | $1.55 | $1.23 | $0.38 | $0.67 | $1.81 | · | |
| Cash / Share | $8.79 | · | · | · | · | · | $2.87 | $3.09 | $3.09 | · | |
| EPS (TTM) | $0.46 | $0.90 | $1.29 | $0.99 | $1.52 | $1.01 | $0.39 | $0.29 | $0.90 | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 56.4% | 46.7% | 21.2% | 47.8% | 12.6% | · | · | · | · | · | |
| Revenue CAGR 3Y | 40.6% | 38.0% | 26.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 35.9% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -48.9% | -30.2% | 30.3% | -34.9% | 50.5% | · | · | · | · | · | |
| EPS CAGR 3Y | -22.6% | -16.0% | 8.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -14.5% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -47.9% | -28.9% | 34.4% | -34.5% | 82.9% | · | · | · | · | · | |
| Net Income CAGR 3Y | -20.8% | -14.4% | 17.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -9.8% | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -31.2% | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.18B | $2.03B | $1.39B | $1.14B | $774M | $687M | $561M | $520M | $356M | · | |
| Net Income TTM | $22M | $43M | $61M | $45M | $69M | $38M | $14M | $11M | $26M | · | |
| Market Cap | $1.21B | · | · | · | · | · | $661M | $686M | $775M | · | |
| Enterprise Value | $1.82B | · | · | · | · | · | $683M | · | · | · | |
| P/E | 53.9 | 35.0 | 29.7 | 29.9 | 48.3 | 18.1 | 47.2 | 68.4 | 26.7 | · | |
| P/S | 0.4 | · | · | · | · | · | 1.2 | 1.3 | 2.2 | · | |
| P/B | 1.6 | · | · | · | · | · | 3.5 | 3.8 | 4.8 | · | |
| P / Cash Flow | 10.6 | · | · | · | · | · | 48.3 | 26.9 | 14.9 | · | |
| P / FCF | 11.6 | · | · | · | · | · | 52.3 | 28.2 | 15.6 | · | |
| EV / EBITDA | 14.7 | · | · | · | · | · | 13.3 | · | · | · | |
| EV / FCF | 17.4 | · | · | · | · | · | 54.1 | · | · | · | |
| EV / Revenue | 0.6 | · | · | · | · | · | 1.2 | · | · | · | |
| Dividend Yield | 0.65% | · | · | · | · | · | 9.3% | 2.6% | 1.4% | · | |
| Earnings Yield | 1.8% | 2.9% | 3.4% | 3.4% | 2.1% | 5.5% | 2.1% | 1.5% | 3.8% | · | |
| Payout Ratio | 35.1% | 9.3% | 102.2% | 31.1% | 42.1% | 135.5% | 437.2% | 163.9% | 40.5% | · | |
| Annual Payout | $8M | $4M | $62M | $14M | $31M | $51M | $62M | $18M | $10M | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $973M | $965M | $951M | $956M | $655M | $620M | $665M | $479M | $486M | $404M | $353M | $348M | $348M | $337M | $294M | $317M | |
| SG&A Expense | $54M | $62M | $60M | $62M | $51M | $44M | $42M | $38M | $36M | $39M | $38M | $29M | $24M | $21M | $24M | $21M | |
| Operating Expenses | $938M | $937M | $932M | $937M | $634M | $600M | $664M | $450M | $456M | $374M | $357M | $309M | $321M | $315M | $282M | $267M | |
| Operating Income | $34M | $29M | $18M | $19M | $20M | $21M | $720.0K | $28M | $30M | $30M | $-4M | $39M | $27M | $22M | $13M | $50M | |
| Interest Expense | · | · | · | · | · | · | · | · | $9M | $8M | · | $4M | $4M | $3M | · | $2M | |
| Interest Income | $6M | $4M | $4M | $4M | $2M | $2M | $3M | $4M | $4M | $4M | $5M | $3M | $3M | $3M | $1M | $223.0K | |
| Other Non-op | $-2M | $662.0K | $703.0K | $445.0K | $1M | $-5M | $353.0K | $3M | $6M | $-4M | $2M | $2M | $1M | $1M | $2M | $-1M | |
| Pretax Income | $27M | $20M | $8M | $6M | $17M | $10M | $-2M | $27M | $32M | $24M | $923.0K | $38M | $31M | $19M | $10M | $41M | |
| Income Tax | $9M | $7M | $944.0K | $5M | $7M | $3M | $6M | $8M | $10M | $7M | $1M | $10M | $14M | $7M | $11M | $17M | |
| Net Income | $20M | $14M | $6M | $373.0K | $9M | $7M | $-7M | $16M | $19M | $15M | $12M | $22M | $13M | $13M | $-3M | $23M | |
| EPS (Basic) | $0.40 | $0.30 | $0.12 | $0.01 | $0.19 | $0.14 | $-0.14 | $0.34 | $0.40 | $0.31 | $0.27 | $0.47 | $0.28 | $0.28 | $-0.08 | $0.52 | |
| EPS (Diluted) | $0.40 | $0.29 | $0.12 | $0.01 | $0.19 | $0.14 | $-0.14 | $0.33 | $0.40 | $0.31 | $0.26 | $0.47 | $0.28 | $0.28 | $-0.06 | $0.50 | |
| Shares (Basic) | 49,115,835 | 48,853,678 | · | 49,217,134 | 49,187,885 | 48,470,682 | · | 47,686,841 | 47,615,096 | 47,260,351 | · | 46,547,502 | 46,482,271 | 46,555,406 | · | 44,946,725 | |
| Shares (Diluted) | 49,778,028 | 49,054,135 | · | 49,473,417 | 49,470,677 | 48,850,666 | · | 48,223,788 | 47,978,491 | 47,699,537 | · | 46,920,607 | 46,778,299 | 46,954,687 | · | 46,152,536 | |
| EBITDA | $34M | $44M | · | $19M | $20M | $27M | · | $28M | $30M | $35M | · | $39M | $27M | $27M | · | $50M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $401M | $478M | $429M | $462M | $340M | $259M | $288M | $348M | $325M | $335M | $294M | $274M | $294M | $275M | $288M | $184M | |
| Short-term Investments | · | · | · | $1M | $2M | $2M | · | $2M | $2M | $2M | · | $3M | $4M | $4M | · | $33M | |
| Receivables | $465M | $467M | $374M | $381M | $349M | · | $276M | · | · | · | · | · | · | $76M | · | $69M | |
| Prepaid Expense | $26M | $26M | $26M | $23M | $22M | $24M | $25M | $21M | $17M | $17M | · | $14M | $15M | $22M | · | $12M | |
| Current Assets | $919M | $1.00B | $863M | $884M | $729M | $613M | $638M | $597M | $570M | $539M | · | $476M | $465M | $455M | · | $444M | |
| PP&E (Net) | $63M | $60M | $57M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | · | · | $87M | · | · | · | $39M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $30M | · | · | · | $25M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $887M | $875M | $865M | $863M | $417M | $416M | $419M | $410M | $410M | $410M | $279M | $276M | $274M | $269M | $269M | $257M | |
| Intangibles | $243M | $257M | $271M | $285M | $106M | $112M | $118M | $109M | $116M | $120M | · | $74M | $74M | $78M | · | $73M | |
| Other Non-current Assets | $28M | $27M | $23M | $23M | $30M | $31M | $17M | $9M | $9M | $4M | · | $9M | $7M | $5M | · | $6M | |
| Total Assets | $2.28B | $2.36B | $2.22B | $2.24B | $1.44B | $1.33B | $1.35B | $1.29B | $1.25B | $1.23B | · | $1.07B | $1.03B | $999M | · | $943M | |
| Accounts Payable | $246M | $221M | $196M | $210M | $120M | $106M | $106M | $95M | $96M | $146M | · | $53M | $50M | $49M | · | $25M | |
| Current Liabilities | $748M | $745M | $615M | $630M | $460M | $361M | $366M | $313M | $310M | $355M | · | $203M | $186M | $173M | · | $156M | |
| Capital Leases | $34M | $30M | $32M | $30M | $29M | $29M | $31M | $31M | $27M | $38M | · | $21M | $18M | $18M | · | $16M | |
| Deferred Tax | $9M | $7M | $5M | $4M | $3M | $4M | $5M | $3M | $3M | $4M | · | $12M | $12M | $14M | · | $5M | |
| Other Non-current Liabilities | $10M | $19M | $17M | $16M | $12M | $15M | $15M | $7M | $8M | $8M | · | $14M | $21M | $22M | · | $13M | |
| Total Liabilities | $1.68B | $1.78B | $1.66B | $1.68B | $904M | $814M | $841M | $778M | $774M | $774M | · | $458M | $444M | $434M | · | $390M | |
| Long-term Debt | $936M | $1.03B | $1.04B | $1.05B | $414M | $416M | $435M | $438M | $442M | $389M | · | $209M | $208M | $206M | · | $202M | |
| Total Debt | $936M | $1.03B | · | $1.05B | $414M | $416M | · | $438M | $442M | $389M | · | $209M | $208M | $206M | · | $202M | |
| Common Stock | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $48.0K | $48.0K | $48.0K | $48.0K | · | $47.0K | $47.0K | $47.0K | · | $45.0K | |
| Paid-in Capital | $488M | $478M | $471M | $473M | $463M | $452M | $426M | $411M | $402M | $395M | · | $363M | $357M | $353M | · | $315M | |
| Retained Earnings | $342M | $323M | $308M | $302M | $302M | $293M | $286M | $293M | $277M | $258M | · | $231M | $209M | $196M | · | $195M | |
| Stockholders' Equity | $830M | $800M | $779M | $776M | $765M | $745M | $713M | $705M | $679M | $653M | · | $594M | $566M | $548M | · | $510M | |
| Liabilities + Equity | $2.28B | $2.36B | $2.22B | $2.24B | $1.44B | $1.33B | $1.35B | $1.29B | $1.25B | $1.23B | · | $1.07B | $1.03B | $999M | · | $943M | |
| Shares Outstanding | · | · | 48,885,358 | · | · | · | 47,929,872 | · | · | · | · | 46,607,356 | 46,553,517 | 46,488,443 | · | 44,884,522 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $15M | $16M | $16M | $7M | $7M | $8M | $7M | $7M | $5M | $5M | $4M | $4M | $4M | $4M | $5M | |
| Stock-based Comp | $12M | $10M | $11M | $8M | $12M | $8M | $15M | $6M | $7M | $6M | $9M | $6M | $4M | $3M | $6M | $4M | |
| Amort. of Intangibles | $14M | $14M | $14M | $14M | $6M | $6M | $5M | $7M | $7M | $7M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Other Non-cash | · | $28M | · | · | · | $-5M | · | · | · | $-20M | · | · | · | $-13M | · | · | |
| Operating Cash Flow | $33M | $68M | $-3M | $10M | $91M | $17M | $-11M | $34M | $23M | $6M | $19M | $15M | $26M | $8M | $85M | $-36M | |
| CapEx | $4M | $4M | $3M | $3M | $1M | $3M | $3M | $2M | $3M | $369.0K | $7M | $4M | $11M | $6M | $886.0K | $3M | |
| Investing Cash Flow | $-6M | $-3M | $-1M | $-534M | $-1M | $-2M | $-33M | $-8M | $-80M | $-71M | $-11M | $-35M | $-5M | $-14M | $13M | $-8M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $-153.0K | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Stock Repurchased | $0 | $3M | $15M | $0 | $0 | $11M | $900.0K | $0 | · | · | · | $150.0K | $10M | $0 | · | $168.0K | |
| Net Stock Activity | · | $-3M | · | · | · | $-11M | · | · | · | · | · | · | · | $0 | · | · | |
| Dividends Paid | $95.0K | $104.0K | $2M | $96.0K | $778.0K | $5M | $2M | $218.0K | $2M | $95.0K | $60M | $1M | $722.0K | $120.0K | $1M | $120.0K | |
| Financing Cash Flow | $-104M | $-16M | $-26M | $648M | $-9M | $-44M | $-15M | $-3M | $47M | $106M | $12M | $-510.0K | $-963.0K | $-7M | $6M | $-6M | |
| Net Change in Cash | $-78M | $49M | $-30M | $124M | $81M | $-30M | $-60M | $23M | $-9M | $41M | $20M | $-20M | $20M | $-13M | $104M | $-50M | |
| Taxes Paid | $11M | $0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $64M | · | · | · | $14M | · | · | · | $6M | · | · | · | $2M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $279.8K | · | · | · | $-410.3K | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.5% | 3.0% | · | 2.0% | 3.1% | 3.3% | · | 5.9% | 6.2% | 7.4% | · | 11.2% | 7.8% | 6.6% | · | 15.8% | |
| Net Margin | 2.0% | 1.5% | · | 0.04% | 1.4% | 1.1% | · | 3.4% | 3.9% | 3.7% | · | 6.3% | 3.8% | 3.9% | · | 8.2% | |
| Pretax Margin | 2.8% | 2.0% | · | 0.59% | 2.6% | 1.6% | · | 5.6% | 6.6% | 5.9% | · | 10.9% | 9.0% | 5.8% | · | 13.0% | |
| EBITDA Margin | 3.5% | 4.6% | · | 2.0% | 3.1% | 4.4% | · | 5.9% | 6.2% | 8.7% | · | 11.2% | 7.8% | 7.9% | · | 15.8% | |
| ROA | 1.1% | 0.78% | · | 0.02% | 0.70% | 0.52% | · | 1.4% | 1.7% | 1.3% | · | 2.2% | 1.3% | 1.4% | · | 2.9% | |
| ROE | 2.5% | 1.9% | · | 0.05% | 1.3% | 0.96% | · | 2.5% | 3.1% | 2.5% | · | 4.0% | 2.5% | 2.6% | · | 5.5% | |
| ROIC | 1.3% | 1.0% | · | 0.20% | 1.1% | 1.1% | · | 1.8% | 1.8% | 2.0% | · | 3.6% | 1.9% | 1.9% | · | 4.7% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.3 | · | 1.4 | 1.6 | 1.7 | · | 1.9 | 1.8 | 1.5 | · | 2.3 | 2.5 | 2.6 | · | 2.8 | |
| Quick Ratio | 1.2 | 1.3 | · | 1.3 | 1.5 | 0.7 | · | 1.1 | 1.1 | 0.9 | · | 1.4 | 1.6 | 2.0 | · | 1.8 | |
| Debt / Equity | 1.1 | 1.3 | · | 1.4 | 0.5 | 0.6 | · | 0.6 | 0.7 | 0.6 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| LT Debt / Equity | 1.1 | 1.2 | · | 1.3 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 0.3 | 0.4 | 0.4 | · | 0.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 3.5 | 4.0 | · | 10.3 | 7.4 | 6.8 | · | 20.7 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.4 | 0.4 | · | 0.3 | |
| Receivables Turnover | 2.4 | 3.6 | · | 4.2 | 3.1 | · | · | · | · | · | · | · | · | 5.1 | · | 7.2 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | · | · | · | · | · | $12.74 | $12.16 | $11.79 | · | $11.37 | |
| Revenue / Share | $19.54 | $19.67 | · | $19.32 | $13.24 | $12.70 | · | $9.93 | $10.14 | $8.48 | · | $7.42 | $7.44 | $7.18 | · | $6.87 | |
| Cash Flow / Share | · | $1.39 | · | · | · | $0.34 | · | · | · | $0.13 | · | · | · | $0.16 | · | · | |
| Cash / Share | · | · | · | · | · | · | · | · | · | · | · | $5.88 | $6.31 | $5.91 | · | $4.10 | |
| EPS (TTM) | $0.82 | $0.61 | · | $0.20 | $0.52 | $0.73 | · | $1.30 | $1.44 | $1.32 | · | $0.97 | $1.00 | $0.98 | · | $1.26 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.84B | $3.53B | · | $2.90B | $2.42B | $2.25B | · | $1.72B | $1.59B | $1.45B | · | $1.33B | $1.30B | $1.22B | · | $1.05B | |
| Net Income TTM | $41M | $30M | · | $10M | $25M | $35M | · | $62M | $68M | $62M | · | $45M | $46M | $45M | · | $58M | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | · | $1.44B | $1.47B | $1.70B | · | $1.75B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $1.37B | $1.38B | $1.62B | · | $1.74B | |
| P/E | 56.6 | 40.2 | · | 141.8 | 47.8 | 42.5 | · | 44.6 | 28.2 | 31.8 | · | 31.8 | 31.6 | 37.2 | · | 31.0 | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | 1.1 | 1.1 | 1.4 | · | 1.7 | |
| P/B | · | · | · | · | · | · | · | · | · | · | · | 2.4 | 2.6 | 3.1 | · | 3.4 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | 5.9 | 6.8 | 8.4 | · | 9.7 | |
| P / Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | 219.6 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 1.0 | 1.1 | 1.3 | · | 1.7 | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | · | 0.25% | 0.16% | 0.77% | · | 0.72% | |
| Earnings Yield | 1.8% | 2.5% | · | 0.71% | 2.1% | 2.4% | · | 2.2% | 3.5% | 3.1% | · | 3.1% | 3.2% | 2.7% | · | 3.2% | |
| Payout Ratio | · | 0.72% | · | · | · | 81.5% | · | · | · | 0.64% | · | · | · | 0.91% | · | · | |
| Annual Payout | $2M | $3M | · | $8M | $8M | $9M | · | $62M | $63M | $62M | · | $4M | $2M | $13M | · | $13M |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Gelir | $3.18B | $2.03B | $1.39B | $1.14B | · |
| Faaliyet Kâr Marjı % | 2.5% | 4.4% | 6.1% | 9.1% | · |
| Net Gelir | $22M | $43M | $61M | $45M | · |
| Seyreltilmiş Hisse Başı Kâr | $0.46 | $0.90 | $1.29 | $0.99 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 1.3 | 0.6 | 0.5 | · | · |
| Cari Oran | 1.4 | 1.7 | 2.1 | · | · |
| Cari Oran | 1.3 | 0.8 | 1.4 | · | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $104M | $44M | $40M | $59M | · |
Kurumsal Sahipler (13F) 227 dosya · $1.6B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
227
Tutulan Değer
$1.6B
Yeni pozisyonlar
55
Çıkan pozisyonlar
16
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 55 (+22 önceki Ç'ye göre) | 16 (-9 önceki Ç'ye göre) | 80 (+16 önceki Ç'ye göre) | 51 (0 önceki Ç'ye göre) | +2.6M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BlackRock, Inc. | $320.228.534 | 6.899.990 | 20,25% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $120.934.018 | 2.605.775 | 7,65% | Hisse senetleri |
| VANGUARD GROUP INC | $105.149.543 | 4.238.192 | 6,65% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $90.333.863 | 1.946.431 | 5,71% | Hisse senetleri |
| STATE STREET CORP | $80.703.741 | 1.738.930 | 5,10% | Hisse senetleri |
| 325 CAPITAL LLC | $74.898.454 | 1.613.843 | 4,74% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $68.147.789 | 1.468.508 | 4,31% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $59.988.313 | 1.292.573 | 3,79% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $54.215.672 | 1.167.974 | 3,43% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $39.548.050 | 852.145 | 2,50% | Hisse senetleri |
| FMR LLC | $31.833.629 | 685.922 | 2,01% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $30.859.865 | 664.940 | 1,95% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30.290.368 | 652.669 | 1,92% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $23.767.026 | 512.110 | 1,50% | Hisse senetleri |
| NORTHERN TRUST CORP | $23.439.092 | 505.044 | 1,48% | Hisse senetleri |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $22.088.422 | 475.941 | 1,40% | Hisse senetleri |
| ROYCE & ASSOCIATES LP | $21.927.797 | 472.480 | 1,39% | Hisse senetleri |
| SteelPeak Wealth, LLC | $21.577.727 | 464.937 | 1,36% | Hisse senetleri |
| MORGAN STANLEY | $20.119.143 | 433.508 | 1,27% | Hisse senetleri |
| Invesco Ltd. | $17.720.731 | 381.830 | 1,12% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $14.248.891 | 307.022 | 0,90% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $12.614.145 | 271.798 | 0,80% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $12.424.235 | 267.706 | 0,79% | Hisse senetleri |
| EARNEST PARTNERS LLC | $12.019.772 | 258.991 | 0,76% | Hisse senetleri |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $11.575.118 | 249.410 | 0,73% | Hisse senetleri |
| Bank of New York Mellon Corp | $10.901.538 | 234.896 | 0,69% | Hisse senetleri |
| LPL Financial LLC | $10.288.911 | 221.696 | 0,65% | Hisse senetleri |
| 683 Capital Management, LLC | $9.746.101 | 210.000 | 0,62% | Hisse senetleri |
| UBS Group AG | $8.908.678 | 191.956 | 0,56% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $8.841.244 | 190.503 | 0,56% | Hisse senetleri |
| ENVESTNET ASSET MANAGEMENT INC | $8.700.111 | 187.462 | 0,55% | Hisse senetleri |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $8.581.255 | 184.901 | 0,54% | Hisse senetleri |
| Public Sector Pension Investment Board | $8.342.012 | 179.746 | 0,53% | Hisse senetleri |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $7.162.316 | 154.327 | 0,45% | Hisse senetleri |
| 1492 Capital Management LLC | $6.773.354 | 145.946 | 0,43% | Hisse senetleri |
| Empowered Funds, LLC | $6.301.503 | 135.779 | 0,40% | Hisse senetleri |
| Nuveen, LLC | $6.164.269 | 132.822 | 0,39% | Hisse senetleri |
| AXA Investment Managers S.A. | $5.882.030 | 207.479 | 0,37% | Hisse senetleri |
| SEI INVESTMENTS CO | $5.718.354 | 123.214 | 0,36% | Hisse senetleri |
| TOWLE & CO | $5.702.072 | 122.863 | 0,36% | Hisse senetleri |
| Rhenman & Partners Asset Management AB | $5.517.592 | 118.888 | 0,35% | Hisse senetleri |
| Emerald Investment Advisers, LLC | $5.339.238 | 115.045 | 0,34% | Hisse senetleri |
| RHUMBLINE ADVISERS | $4.970.861 | 107.108 | 0,31% | Hisse senetleri |
| Legal & General Group Plc | $4.555.234 | 98.152 | 0,29% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $4.547.902 | 97.994 | 0,29% | Hisse senetleri |
| Swiss National Bank | $4.151.096 | 89.444 | 0,26% | Hisse senetleri |
| Westmount Partners, LLC | $3.608.610 | 77.755 | 0,23% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.542.847 | 76.338 | 0,22% | Hisse senetleri |
| Insight Wealth Strategies, LLC | $3.513.495 | 143.291 | 0,22% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $3.464.321 | 74.646 | 0,22% | Hisse senetleri |
Aktivistler ve %5+ sahipler 11 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Allied Physicians of California, a Professional Medical Corporation ×9 başvurular | 18 Şubat 2025 | 11,00% | Değişiklik | Sermaye yapısı | SEC |
| Kenneth T. Sim ×4 başvurular | 24 Şubat 2020 | · | İlk başvuru | · | SEC |
| Thomas S. Lam ×4 başvurular | 24 Şubat 2020 | · | İlk başvuru | · | SEC |
| Lakhi Sakhrani ×4 başvurular | 24 Şubat 2020 | · | İlk başvuru | · | SEC |
| 16 Eylül 2019 | · | İlk başvuru | · | SEC | |
| Adrian Vazquez, M.D. ×2 başvurular | 19 Aralık 2017 | · | İlk başvuru | M&A / satış | SEC |
| Warren Hosseinion, M.D. ×2 başvurular | 15 Aralık 2017 | · | İlk başvuru | M&A / satış | SEC |
| NNA OF NEVADA, INC., FRESENIUS MEDICAL CARE HOLDINGS, INC., FRESENIUS MEDICAL CARE AG & CO. KGaA ×3 başvurular | 13 Aralık 2017 | · | İlk başvuru | · | SEC |
| Network Medical Management, Inc. ×3 başvurular | 12 Aralık 2017 | · | İlk başvuru | · | SEC |
| Warren Hosseinion | 25 Haziran 2008 | · | İlk başvuru | · | SEC |
| Adrian Vazquez | 25 Haziran 2008 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 32 içeriden öğrenenler · 12 yöneticiler · 14 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Brandon Sim | CEO and President | 05 Eylül 2026 F | 1.238.861 | 0 | 0 | $0 |
| Warren Hosseinion | Co-Chief Executive Officer | 28 Kasım 2018 S | 524.438 | 0 | 0 | $0 |
| Chandan Basho | COO and CFO | 05 Eylül 2026 F | 157.820 | 0 | 0 | $0 |
| Mihir Shah | Chief Financial Officer | 15 Ocak 2018 M | 19.932 | 0 | 0 | $0 |
| Mitchell Creem | Chief Financial Officer | 31 Mart 2015 A | · | 0 | 0 | $0 |
| Kyle Francis | EVP and CFO | 22 Ağustos 2013 A | 2.100.000 | 0 | 0 | $0 |
| Hing Ang | Chief Operating Officer | 26 Mayıs 2020 D | 38.316 | 0 | 0 | $0 |
| John Vong | SVP - Accounting (PAO) | 15 Eylül 2026 F | 22.330 | 0 | 0 | $0 |
| Kenneth T. Sim | Executive Chairman | 06 Nisan 2026 A | 739.407 | 0 | 0 | $0 |
| Dinesh M. Kumar | Chief Medical Officer | 01 Nisan 2026 F | 177.655 | 0 | 0 | $0 |
| Adrian Vazquez | Chief Medical Officer | 28 Nisan 2021 S | 371.004 | 0 | 0 | $0 |
| Mark Meyers | Chief Strategy Officer | 22 Ekim 2013 A | · | 0 | 0 | $0 |
| Mitchell W Kitayama | Yönetim kurulu üyesi | 31 Ağustos 2026 D | 24.337 | 0 | 0 | $0 |
| David Schmidt | Yönetim kurulu üyesi | 14 Ağustos 2026 M | 36.019 | 0 | 0 | $0 |
| Matthew Mazdyasni | Yönetim kurulu üyesi | 10 Haziran 2026 A | 39.288 | 0 | 0 | $0 |
| John Chiang | Yönetim kurulu üyesi | 10 Haziran 2026 A | 35.373 | 0 | 0 | $0 |
| Linda Dong | Yönetim kurulu üyesi | 10 Haziran 2026 A | 97.133 | 0 | 0 | $0 |
| Weili Dai, | Yönetim kurulu üyesi | 10 Haziran 2026 A | 18.188 | 0 | 0 | $0 |
| Thomas S. Lam | Yönetim kurulu üyesi | 06 Nisan 2026 A | 465.657 | 0 | 0 | $0 |
| Gary Augusta | Yönetim kurulu üyesi | 17 Ağustos 2018 S | 152.997 | 0 | 0 | $0 |
| Edward Schreck | Yönetim kurulu üyesi | 14 Eylül 2016 A | · | 0 | 0 | $0 |
| Suresh Nihalani | Yönetim kurulu üyesi | 14 Eylül 2016 A | 800.000 | 0 | 0 | $0 |
| Allied Physicians of California, a Professional Medical Corporation | 10% sahip | 15 Şubat 2025 J | 6.132.802 | 0 | 0 | $0 |
| Bradley S Shepherd | 10% sahip | 20 Mayıs 2005 S | 10.200.000 | 0 | 0 | $0 |
| Glenn Sobotka | · | 07 Ağustos 2026 D | 2.246 | 0 | 0 | $0 |
| Albert Waichow Young | · | 02 Aralık 2022 J | 1.184.749 | 0 | 0 | $0 |
| Eric Chin | · | 31 Mart 2022 F | 20.844 | 0 | 0 | $0 |
| Michael F. Eng | · | 20 Ocak 2022 A | 4.890 | 0 | 0 | $0 |
| Mark Fawcett | · | 20 Ocak 2022 A | 30.000 | 0 | 0 | $0 |
| BATES ERNEST A | · | 20 Ocak 2022 A | · | 0 | 0 | $0 |
| Li Yu | · | 11 Kasım 2020 A | · | 0 | 0 | $0 |
| Network Medical Management, Inc. | · | 08 Aralık 2017 J | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 46 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| RZV · Invesco Exchange-Traded Fund Trust | 0,93% | 73.829 SH | 02 Ekim 2026 | Günlük |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0,80% | 39.995 SH | 02 Ekim 2026 | Günlük |
| QIDX · Spinnaker ETF Series | 0,31% | 3.368 NS | 31 Temmuz 2026 | N-PORT |
| IHF · iShares Trust | 0,24% | 81.583 SH | 11 Eylül 2026 | Günlük |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,23% | 128.133 SH | 02 Ekim 2026 | Günlük |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,21% | 90.075 SH | 19 Ağustos 2026 | Günlük |
| EBIT · Harbor ETF Trust | 0,19% | 624 NS | 31 Temmuz 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,12% | 48.925 SH | 19 Ağustos 2026 | Günlük |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 19.716 NS | 31 Temmuz 2026 | N-PORT |
| IWO · iShares Trust | 0,11% | 428.254 SH | 11 Eylül 2026 | Günlük |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,11% | 147.980 SH | 19 Ağustos 2026 | Günlük |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,10% | 6.438 SH | 02 Ekim 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 63.102 SH | 02 Ekim 2026 | Günlük |
| VBK · VANGUARD INDEX FUNDS | 0,06% | 591.784 SH | 19 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 262.660 SH | 19 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,06% | 1.164.990 SH | 11 Eylül 2026 | Günlük |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 10.366 NS | 31 Temmuz 2026 | N-PORT |
| RSSL · Global X Funds | 0,05% | 21.812 NS | 31 Temmuz 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 37.908 SH | 11 Eylül 2026 | Günlük |
| SMDX · Tidal Trust III | 0,05% | 1.882 NS | 31 Temmuz 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,05% | 117.567 NS | 31 Temmuz 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,05% | 18.796 NS | 31 Temmuz 2026 | N-PORT |
| ISCG · iShares Trust | 0,05% | 12.335 SH | 11 Eylül 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,04% | 183.061 NS | 31 Temmuz 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,03% | 134.131 SH | 19 Ağustos 2026 | Günlük |
| DFAT · Dimensional ETF Trust | 0,03% | 108.048 NS | 31 Temmuz 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 21.507 NS | 31 Temmuz 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,02% | 3.190 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 487.188 SH | 19 Ağustos 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,02% | 1.022.756 SH | 19 Ağustos 2026 | Günlük |
| WSML · iShares Trust | 0,02% | 2.757 SH | 11 Eylül 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,01% | 124.687 NS | 31 Temmuz 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 4.223 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 6.176 NS | 31 Temmuz 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 3.078 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 13.356 NS | 31 Temmuz 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,00% | 10.954 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 12.752 SH | 03 Eylül 2026 | Günlük |
| ITOT · iShares Trust | 0,00% | 56.129 SH | 11 Eylül 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,00% | 12.032 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.417.307 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.772 SH | 19 Ağustos 2026 | Günlük |
| IJR · iShares Trust | · | 2.590.268 SH | 10 Eylül 2026 | Günlük |
| IJS · iShares Trust | · | 378.419 SH | 08 Eylül 2026 | Günlük |
| XJR · iShares Trust | · | 5.875 SH | 31 Ağustos 2026 | Günlük |
| ISCB · iShares Trust | · | 1.764 SH | 11 Eylül 2026 | Günlük |
ASTH Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 16 analist
AL
Medyan hedef
$53.00
+47,7%
6 37,5%
Güçlü Al
8 50,0%
Al
2 12,5%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
9 analist · 2026-10-04Ortalama hedef $51.67 +44,0%
← Tüm hedeflerin altında
Mevcut fiyat $35.88
Düşük$41.00
Ortalama$51.67
Yüksek$65.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ASTH | $1.21B | 53.9 | 56.4% | 0.71% | 3.0% | · |
| NEO | $1.51B | -49.0 | 10.1% | -14.8% | -12.8% | 43.2% |
| MD | $1.77B | 11.0 | -4.9% | 8.6% | 20.3% | · |
| ADUS | · | 20.6 | 23.2% | · | · | · |
| WGS | · | · | · | · | · | · |
| AMN | $606M | -6.4 | -8.5% | -3.5% | -15.3% | 28.3% |
| AGL | $7.14B | · | -2.1% | -6.6% | -146.1% | · |
| PNTG | $975M | 33.5 | 36.3% | 3.1% | 8.4% | · |
| OMDA | $922M | -45.1 | 53.2% | -4.9% | -5.8% | 65.7% |
| INNV | $1.61B | -592.5 | 15.9% | -0.26% | -1.1% | 23.0% |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 10, 2026